Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

[Full Text]
Displaying Investigations 1 to 60 of 60 found
From 7 References


Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
NUCKS1/PM20D1
t(1;1)(q32;q32)

Hu et al 2018, Nucleic Acids Res
  Squamous cell carcinoma Uterus, cervix
ARL8A/UBE2T
t(1;1)(q32;q32)
  Adenocarcinoma Uterus, corpus
ATP2B4/PRELP
t(1;1)(q32;q32)
  Mesenchymal tumor, NOS Unknown site
ATP2B4/OPTC
t(1;1)(q32;q32)
  Adenocarcinoma Stomach
CD46/MAPKAPK2
t(1;1)(q32;q32)
  Malignant melanoma Skin
CD55/NEK2
t(1;1)(q32;q32)
  Malignant melanoma Skin
CDK18/CNTN2
t(1;1)(q32;q32)
  Mesenchymal tumor, NOS Unknown site
CNTN2/PKP1
t(1;1)(q32;q32)
  Adenocarcinoma Prostate
CR1L/C1orf116
t(1;1)(q32;q32)
  Transitional cell carcinoma Bladder
DIEXF/TRAF3IP3
t(1;1)(q32;q32)
  Adenocarcinoma Uterus, corpus
DSTYK/LEMD1
t(1;1)(q32;q32)
  Adenocarcinoma Stomach
DSTYK/NUCKS1
t(1;1)(q32;q32)
  Malignant epithelial tumor, special type Uterus, corpus
DSTYK/CSRP1
t(1;1)(q32;q32)
  Adenocarcinoma Prostate
DTL/INTS7
t(1;1)(q32;q32)
  Adenocarcinoma Liver
ETNK2/REN
t(1;1)(q32;q32)
  Adenocarcinoma Prostate
INTS7/DTL
t(1;1)(q32;q32)
  Squamous cell carcinoma Lung
IRF6/SRGAP2
t(1;1)(q32;q32)
  Mesenchymal tumor, NOS Unknown site
KDM5B/PPP1R12B
t(1;1)(q32;q32)
  Adenocarcinoma Uterus, corpus
LGR6/NAV1
t(1;1)(q32;q32)
  Astrocytoma, grade I-II Brain
NFASC/ATP2B4
t(1;1)(q32;q32)
  Malignant melanoma Skin
NUCKS1/RAB29
t(1;1)(q32;q32)
  Astrocytoma, grade I-II Brain
PLEKHA6/LRRN2
t(1;1)(q32;q32)
  Adenocarcinoma Prostate
RPS6KC1/VASH2
t(1;1)(q32;q32)
  Malignant melanoma Skin
SMYD2/LPGAT1
t(1;1)(q32;q32)
  Adenocarcinoma Liver
SMYD2/PROX1
t(1;1)(q32;q32)
  Malignant melanoma Skin
SYT14/HSD11B1
t(1;1)(q32;q32)
  Embryonal nervous system tumor, special type Adrenal
SYT2/KDM5B
t(1;1)(q32;q32)

Maher et al 2009, Nature
  Adenocarcinoma Prostate
SLC45A3/ELK4
t(1;1)(q32;q32)

Rickman et al 2009, Cancer Res
  Nonneoplastic epithelial disorder/lesion Prostate
SLC45A3/ELK4
t(1;1)(q32;q32)
  Adenocarcinoma Prostate
SLC45A3/ELK4
t(1;1)(q32;q32)

Shah et al 2013, BMC Genomics
  Astrocytoma, grade III-IV/Glioblastoma Brain
PIK3C2B/DSTYK
t(1;1)(q32;q32)
  Astrocytoma, grade III-IV/Glioblastoma Brain
PLEKHA6/PIK3C2B
t(1;1)(q32;q32)
  Astrocytoma, grade III-IV/Glioblastoma Brain
NFASC/SOX13
t(1;1)(q32;q32)
  Astrocytoma, grade III-IV/Glioblastoma Brain
NFASC/PRELP
t(1;1)(q32;q32)
  Astrocytoma, grade III-IV/Glioblastoma Brain
NUCKS1/PM20D1
t(1;1)(q32;q32)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Prostate
ELK4/SLC26A9
t(1;1)(q32;q32)
  Adenocarcinoma Prostate
RCOR3/RPS6KC1
t(1;1)(q32;q32)
  Squamous cell carcinoma Lung
PPP1R12B/LGR6
t(1;1)(q32;q32)
  Adenocarcinoma Lung
CD55/C4BPA
t(1;1)(q32;q32)
  Adenocarcinoma Lung
RPS6KC1/CD34
t(1;1)(q32;q32)
  Astrocytoma, grade I-II Brain
NFASC/PPP1R12B
t(1;1)(q32;q32)
  Astrocytoma, grade I-II Brain
NUAK2/CYB5R1
t(1;1)(q32;q32)
  Squamous cell carcinoma Oral cavity
RASSF5/IKBKE
t(1;1)(q32;q32)
  Squamous cell carcinoma Oral cavity
NUAK2/LEMD1
t(1;1)(q32;q32)
  Squamous cell carcinoma Oral cavity
MAPKAPK2/SRGAP2
t(1;1)(q32;q32)
  Astrocytoma, grade III-IV/Glioblastoma Brain
NFASC/SOX13
t(1;1)(q32;q32)
  Astrocytoma, grade III-IV/Glioblastoma Brain
NFASC/PRELP
t(1;1)(q32;q32)
  Astrocytoma, grade III-IV/Glioblastoma Brain
ATP2B4/NFASC
t(1;1)(q32;q32)
  Astrocytoma, grade III-IV/Glioblastoma Brain
NFASC/LRRN2
t(1;1)(q32;q32)
  Adenocarcinoma Breast
PHLDA3/MYBPH
t(1;1)(q32;q32)
  Adenocarcinoma Breast
ADIPOR1/CYB5R1
t(1;1)(q32;q32)
  Adenocarcinoma Breast
KCNH1/LPGAT1
t(1;1)(q32;q32)
  Adenocarcinoma Breast
TMEM206/RCOR3
t(1;1)(q32;q32)
  Adenocarcinoma Breast
TIMM17A/RASSF5
t(1;1)(q32;q32)
  Adenocarcinoma Breast
LGR6/GPR37L1
t(1;1)(q32;q32)
  Adenocarcinoma Breast
HHAT/SERTAD4
t(1;1)(q32;q32)
  Adenocarcinoma Breast
HHAT/CD34
t(1;1)(q32;q32)
  Adenocarcinoma Breast
C1orf132/PROX1
t(1;1)(q32;q32)
  Adenocarcinoma Breast
ZC3H11A/TMCC2
t(1;1)(q32;q32)

Zhao et al 2017, Oncotarget
  Adenocarcinoma Prostate
SLC45A3/ELK4
t(1;1)(q32;q32)